According to analysts at Coherent Market Insights, the global Sevoflurane market accounted for more than USD 370.2 Million in 2022 and is expected to reach USD 522.8 Million by 2030, growing at a CAGR of 4.4% from 2022 to 2030.
Sevoflurane is a nonflammable, sweet-smelling and highly fluorinated methyl isopropyl ether which belongs to the class of general anesthetics as it is used during surgery. It is administered into a patient through inhalation, it can be used solely in some cases it is used by combining with some other anesthetic. Sevoflurane aids in keeping a patient’s pulse rate and blood pressure stable. It also help in managing discomfort after surgery.
Request Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/5031
Market Drivers:
Rising number of research and development activities is estimated to augment growth of the global sevoflurane market over the forecast period. For instance, Infant Hospital and Shanghai First Maternity declared the launch of their clinical trial for examining the safety and efficacy of sub anesthetic sevoflurane used for the treatment-resistant depression.
Furthermore, key players were focusing on the expansion of their business in surgical centers is estimated to fuel growth of the global sevoflurane market over the forecast period. For instance, Pristyn Care declared their plans of expansion to almost 800 surgical centers by 2020, in February, 2020. Currently they are open in multiple cities across India.
Impact of COVID – 19:
The pandemic affected several markets around the world. The pandemic affected the demand and supply of many healthcare products in three ways. Firstly, they affected the production and demand directly and also created disruptions in distribution channels. COVID-19 also had a huge financial impact on many firms and the financial market.
Moreover, the pandemic is estimated to be neutral in the growth of the global sevoflurane market over the forecast period, due to rise in research and developmental activities regarding sevoflurane in patients suffering from COVID-19. For instance, Sunnybrook Health Sciences Centre started a Phase 3 clinical study on Sevoflurane inhalant and Isoflurane Inhalant in June 2020. These are used during the treatment of Hypoxic Respiratory Failure and COVID-19. The main aim of this study was to sedate patients suffering from COVID-19 and were in the Intensive Care Unit.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5031
Key Takeaways:
The global sevoflurane market is estimated to exhibit a CAGR of 4.4% during the forecast period. North America is estimated to witness robust growth during the forecast period, due to increased launch of vaporizers or inhaling devices. For instance, Gofire, a U.S. based healthcare technology company declared the launch of their metered-dose Inhaler in November 2019. The company develops software and hardware solutions for health tracking, medication management and dose delivery.
Key players active in the global sevoflurane market are Troikaa Pharmaceuticals Limited, Abbott Laboratories, Rewine Pharmaceutical, Baxter, Wellona Pharma, Piramal Pharma Solutions, Abbvie, Manus Aktteva Biopharma LLP, Lunan Pharmaceutical Group and Maruishi Pharmaceutical Co.,Ltd.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐔𝐩𝐭𝐨 4𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐚𝐭:
https://www.coherentmarketinsights.com/insight/buy-now/5031
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
- Market Dynamics
- Global Sevoflurane Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on demand and supply of sevoflurane
- Impact of COVID-19 on the overall healthcare sector
- Global Sevoflurane Market, By Application, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global Sevoflurane Market, By Distribution Channel, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global Sevoflurane Market, By Region, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
- North America
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Abbott Laboratories*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited
- Abbott Laboratories*
- Company Profiles
*Key pointers provided are also applicable to other companies covered in the scope of the report.
- Section
- Research Methodology
- About us
- Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837